You are now viewing 1 - 10 of 20 results
November 29, 2012 | Human Capital Blog Post
Patients are more likely to get influenza and pneumococcal vaccinations when the responsibility for immunization administration is shifted to non-physician health care professionals, especially nurses.
March 26, 2012 | Journal Article
A study of California kindergarteners' exposure to personal belief exemptions (PBEs) from vaccinations at school found that PBE exposure increased from 2008 to 2010, indicating that more children are exposed to the risk of disease.
August 7, 2012 | Story
Yet another study—the first one to assess sleep and vaccine effectiveness outside of the laboratory setting—has found that sleeping fewer than seven hours a night significantly impairs the ability of the immune system to do its job. “Our study revea ...
August 1, 2012 | News Release
RWJF Health & Society Scholar finds that losing sleep can reduce the effectiveness of vaccinations.
June 14, 2012 | Story
Study finds intentionally unvaccinated students may be putting other children at risk.
March 20, 2012 | Human Capital Blog Post
The Centers for Disese Control and Prevention recommends pertussis vaccination for adults in close contact with newborns. The immunization of household contacts provides early protection for infants, who do not gain immunity to pertussis until they ...
March 1, 2011 | Journal Article
The objective of this study was to determine the effectiveness of a 23-valent-polysaccharide pneumococcal vaccine (PPV-23) and pneumococcal conjugate vaccine (PCV-7) in reducing adult pneumococcal mortality.
November 1, 2010 | Journal Article
State actions requiring adolescent girls to receive the human papillomavirus (HPV) vaccine created controversy following the vaccine’s approval in 2006.
January 3, 2008 | Journal Article
This research reports on an effort to increase vaccination rates in children, particularly high-risk children, across numerous hospitals, clinics and community-based pediatric practices.
April 1, 2006 | Journal Article
In 2000, a heptavalent pneumococcal conjugate vaccine (PCV7) was licensed and recommended for all children aged 2 to 23 months. This study compares the rates of invasive pneumococcal disease (IPD) in young infants before and after the addition of PC ...